Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer
Abstract Background Angiotensin-converting enzyme 2 (ACE2) is known as a tumor suppressor and lowly expressed in most cancers. The expression pattern and role of ACE2 in breast cancer (BC) have not been deeply elucidated. Methods A systematic pan-cancer analysis was conducted to assess the expressio...
Main Authors: | Jie Mei, Yun Cai, Rui Xu, Xinqian Yu, Xu Han, Miaomiao Weng, Lingyan Chen, Tao Ma, Tianshu Gao, Fei Gao, Tiansong Xia, Yichao Zhu, Yan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Biological Procedures Online |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12575-022-00177-9 |
Similar Items
-
The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
by: Marco Prato, et al.
Published: (2024-03-01) -
Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?
by: Shakhi Shylesh C.M, et al.
Published: (2022-01-01) -
The Effect of Local Renin Angiotensin System in the Common Types of Cancer
by: Moudhi Almutlaq, et al.
Published: (2021-09-01) -
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
by: Minela Aida Maranduca, et al.
Published: (2022-09-01) -
Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
by: Thomas Walther, et al.
Published: (2021-07-01)